The deregulation of serine protease activity is a common feature of neurological injury, but little is known regarding their mechanisms of action or whether they can be targeted to facilitate repair. In this study we demonstrate that the thrombin receptor (Protease Activated Receptor 1, (PAR1)) serves as a critical translator of the spinal cord injury (SCI) proteolytic microenvironment into a cascade of pro-inflammatory events that contribute to astrogliosis and functional decline. PAR1 knockout mice displayed improved locomotor recovery after SCI and reduced signatures of inflammation and astrogliosis, including expression of glial fibrillary acidic protein (GFAP), vimentin, and STAT3 signaling. SCI-associated elevations in pro-inflammatory cytokines such as IL-1β and IL-6 were also reduced in PAR1-/-mice and co-ordinate improvements in tissue sparing and preservation of NeuNpositive ventral horn neurons, and PKCγ corticospinal axons, were observed. PAR1 and its agonist's thrombin and neurosin were expressed by perilesional astrocytes and each agonist increased the production of IL-6 and STAT3 signaling in primary astrocyte cultures in a PAR1-dependent manner. In turn, IL-6-stimulated astrocytes increased expression of PAR1, thrombin, and neurosin, pointing to a model in which PAR1 activation contributes to increased astrogliosis by feedforward-and feedback-signaling dynamics. Collectively, these findings identify the thrombin receptor as a key mediator of inflammation and astrogliosis in the aftermath of SCI that can be targeted to reduce neurodegeneration and improve neurobehavioral recovery.
Introduction
The aberrant activity of serine proteases, including thrombin is a fundamental feature of many neurological conditions, including hemorrhagic, hypoxic, oncogenic, traumatic and infectious injuries. Elevations can occur due to protease leakage across a damaged blood brain barrier or as a consequence of up regulation by CNS endogenous cells (Cunningham et al. 1993; Scarisbrick et al. 1997 Scarisbrick et al. , 2002 Scarisbrick et al. , 2008 Gingrich and Traynelis 2000; Suo et al. 2002; Junge et al. 2003; Chen et al. 2012; Drucker et al. 2013) . Thrombin is known well for its ability to cleave soluble fibrinogen releasing fibrin monomers that support hemostasis. In addition, thrombin is a high affinity agonist for Protease Activated Receptor 1 (PAR1), also known as the thrombin receptor (Vu et al. 1991) . PAR1 is a seven transmembrane guanosine nucleotidebinding protein (G-protein-coupled) receptor that is activated by protease-mediated hydrolysis within its extracellular N-terminus.
While PAR1 has highest affinity for thrombin, it is also activated by plasmin, activated protein C, granzyme A, MMP-1 (Adams et al. 2011) , and at least a subset of kallikreins (Vandell et al. 2008; Burda et al. 2013; Yoon et al. 2013) . Signaling at PAR1 is emerging as an important translator of the extracellular proteolytic microenvironment into cellular responses that contribute to tissue injury, remodeling and regeneration. There are 4 PARs and each is expressed in the CNS (Striggow et al. 2000) . PAR1 is by far the most abundant family member in both the 
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